市場調查報告書

轉基因細胞培養補充品的全球市場分析、預測:基因改造補充品產品、用途、地區的焦點 (2018-2028年)

Global Recombinant Cell Culture Supplements Market: Focus on Recombinant Supplement Products, Applications, and Region - Analysis and Forecast, 2018 to 2028

出版商 BIS Research Inc. 商品編碼 755518
出版日期 內容資訊 英文 200 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
轉基因細胞培養補充品的全球市場分析、預測:基因改造補充品產品、用途、地區的焦點 (2018-2028年) Global Recombinant Cell Culture Supplements Market: Focus on Recombinant Supplement Products, Applications, and Region - Analysis and Forecast, 2018 to 2028
出版日期: 2018年12月07日內容資訊: 英文 200 Pages
簡介

全球轉基因細胞培養補充品市場規模,預計至2028年將達到7億8,860萬美元的規模。

本報告提供全球轉基因細胞培養補充品市場調查,市場概要,市場成長的各種影響因素及市場機會分析,競爭分析,法規、專利趨勢,各產品、用途、地區/主要國家趨勢與市場規模的變化與預測,主要企業簡介等資訊彙整。

摘要整理

第1章 市場概要

  • 細胞培養的基礎
  • 培養基、補充品所扮演的角色
  • 無血清培養基 vs. 含血清培養基
  • 限制培養基的技術進步及轉基因細胞培養補充品的重要性
  • 轉基因細胞培養補充品的市場情況
  • 市場規模估計的前提條件、限制事項

第2章 市場動態

  • 市場成長促進因素
  • 阻礙市場成長要素
  • 市場機會

第3章 產業考察

  • 法規情形
  • 專利形勢

第4章 競爭情形

  • 主要的發展策略
  • 市場佔有率分析

第5章 全球轉基因細胞培養補充品市場:各產品

  • 概要
  • 補充品
    • 基因改造白蛋白 (rAlbumin)
    • 基因改造胰島素 (rInsulin)
    • 基因改造表皮成長因素 (rEGF)
    • 基因改造轉鐵蛋白 (rTransferrin)
    • 基因改造胰蛋白酶 (rTrypsin)
    • 基因改造胰島素先生成長因素 (rIGF)
    • 基因改造幹細胞因素 (rSCF)
    • 基因改造rAprotinin
    • 基因改造rLysozyme
    • 其他

第6章 全球轉基因細胞培養補充品市場:各用途

  • 概要
  • 幹細胞、再生醫療
  • 生物生產
  • 大學、研究用途

第7章 全球轉基因細胞培養補充品市場:各地區

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 其他 (RoW)

第8章 企業簡介

  • BBI Solutions
  • Corning Incorporated
  • Evercyte GmbH
  • Gemini Bio-Products
  • HiMedia Laboratories
  • InVitria
  • Irvine Scientific
  • Kingfisher Biotech, Inc.
  • Lonza Group
  • Merck KGaA
  • Novozymes
  • PeproTech, Inc.
  • Repligen Corporation
  • Shenandoah Biotechnology
  • Sino Biological Inc.
  • STEMCELL Technologies Inc.
  • Thermo Fisher Scientific
  • Albumedix

第9章 調查範圍、調查手法

目錄
Product Code: BH074A

Global Recombinant Cell Culture Supplements Market to Reach $788.6 million by 2028, BIS Research Report

The process of cell culture involves the growth or proliferation of cells extracted from plant or animal sources under controlled conditions in an artificial media. Cell culture is an integral part of biotechnology and finds usage in various applications both commercial and research. Cell culture studies are now employed in the field of genetics, cell therapy, and regenerative medicine, among others. Culturing of cells under laboratory condition allows to study both physiology and biochemistry of cells, which further offers research scopes that are difficult to conduct in-vivo. The effects of drugs or other compounds can easily be tested on cultured cells by controlling parameters such as culture medium, culture conditions, population density, and growth rate. Furthermore, it offers huge prospects in the field of genetics and allows investigating the role of different genes.

Defined supplements in the cell culture media has shown promising impact since decades, aiding in the growth and productivity and maintaining the consistency of cultured cells. With the rise in the demand for cell culture optimization projects, there is a paradigm shift toward the increased application of defined, animal-free supplements for biopharmaceutical, vaccine, and stem cell manufacturing. Recombinant proteins serve as defined supplements in the cell culture media that boost the growth, productivity, and consistency of cultured cells. The use of these supplements acted as a major driving factor toward the adoption of serum-free media for culturing cells and development of cell-lines. The market is expected to grow due to the benefits of recombinant supplements over normal animal-derived supplements. Recombinant cell culture supplements are purer than animal-derived supplements in terms of consistency and safety profile. They are also cheaper and require less raw materials to form a complete cell culture media as compared to their animal counterparts. Other factors include rising investment in the R&D of life sciences and increasing demand for cell culture supplements.

The global recombinant cell culture supplements market is segmented based on products into various recombinant products, such as recombinant insulin, recombinant transferrin, recombinant trypsin, recombinant albumin, recombinant aprotinin, and recombinant epidermal growth factor, among others. On the basis of the application of these recombinant supplement products, the market can be segmented into stem cells and regenerative medicine, bioproduction, and academics and research. The market analysis includes an in-depth examination of the key ecosystem players, key strategies, and developments taking place in this market. Additionally, it includes market dynamics (market drivers, opportunities, and challenges) and industry analysis. Geographically, the market can be segmented into five distinct regions including, North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World.

The purpose of the study is to gain a holistic view of the global recombinant cell culture supplements market in terms of various factors influencing it such as key market trends, competitive and regulatory aspects of the market and scientific innovations with respect to product evolution. The scope of the report is centred upon conducting a detailed study of the solutions allied with recombinant cell culture supplements market, which involves wide range of products used in biotechnological applications. The recombinant cell culture supplements market is segmented into three different parts: 'by products', 'by application, and 'by region'. The report offers the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering the market.

This research report aims at answering questions related to various aspects of the global market with the help of the key factors driving the market, threats that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The study considers the growth-share matrix model for a comprehensive study of the global recombinant cell culture supplements market and assesses the factors governing the same. Detailed product mapping have been included in the report. The market (by region) has been further sub-segmented in various countries, and in each sub-segment the key market trends, list of the key players, and recent developments have been discussed.

The answers to the following key questions can be derived from this report:

  • What are the major market drivers, restraints, and opportunities in the global recombinant cell culture supplements market?
  • What were the market shares of the leading segments and sub-segments of the global recombinant cell culture supplements market in 2017, and what will be the share in 2028
  • How will each segment of the global recombinant cell culture supplements market grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2028?
  • What are the influencing factors that may affect the market share of the key players?
  • What are the key developmental strategies implemented by the key players to stand out in this market?
  • What are the major regulatory authorities/associations/consortiums affecting the global recombinant cell culture supplements market?
  • What are the types of recombinant cell culture supplement products in market and what are their market shares?
  • In 2017, which recombinant supplement type was the dominant type in the market in terms of revenue?
  • Which recombinant supplement type is expected to have the highest CAGR during the forecast period?
  • How has the market been segmented based on application? In 2017, which application area had the largest share and the fastest growth rate in the global recombinant cell culture supplements market?
  • Which geographical region will contribute to the highest sales of the recombinant cell culture supplements during the forecast period, and which will have the highest CAGR?

The report also profiles 17 companies including several key players, such as Thermo Fisher Scientific, Hi-Media Laboratories, BBI Solutions, PeproTech, Inc., InVitria, Sino Biologicals, STEMCELL Technologies, Irvine Scientific, Merck KGaA, Corning Incorporated, Gemini Bio-Products, Novozyme A/S, and Repligen Corporation, among others.

Executive Summary

With advancement in technology, techniques, and methodology, several innovative products are developed and commercialized by various industries into the market. Development in biotech and healthcare industries has led to the emergence of modern day cell culture process and techniques. Cell cultures are currently used for various applications such as bioproduction of vaccines, monoclonal antibodies, and proteins, among others. Also, research and developmental activities have increased the usage of cell culture techniques for the genetic engineering, genomics, and therapeutic research. Cell culture involves different types of products for the growth of cells such as media, sera, reagents, and supplements. Supplements help in the growth of the cell lines and culture.

The global recombinant cell culture supplements market was valued $230.5 million in 2017 and is anticipated to reach $788.6 million by 2028. The market is expected to grow due to the benefits of recombinant supplements over normal animal-derived supplements. Recombinant cell culture supplements are purer than animal-derived supplements in terms of consistency and safety profile. They are also cheaper and require less raw materials to form a complete cell culture media as compared to their animal counterparts. Other factors supporting the growth of the market include increasing investment in the R&D of life sciences and biotechnology industries.

The purpose of the study is to gain a holistic view of the global recombinant cell culture supplements market in terms of various factors influencing it such as key market trends, competitive and regulatory aspects of the market, and scientific innovations into biotechnology and cell culture fields. The scope of the report is centered upon conducting a detailed study of the solutions allied with the recombinant cell culture supplements market, involving products used for different applications such as bioproduction, research and academics, and stem cell and regenerative medicine. The global recombinant cell culture supplements market is segmented into three different parts: by products, by application, and by region.

Based on applications, the market can be sub-segmented into stem cell and regenerative medicine, bioproduction, and academic and research. In 2017, stem cell and regenerative medicine was estimated to be the dominant application segment due to the increased demand for investment in the stem cell and regenerative medicine industry in developed as well as developing nations. However, the academic and research industry is expected to register the highest CAGR due to the rising investments and increased regulatory support for this industry. As recombinant supplements ensure enhanced cell viability and improved batch-to-batch consistency, they are increasingly used for research.

The recombinant cell culture supplements market can be further segmented based on the type of recombinant products into transferrin, insulin, albumin, trypsin, aprotinin, lysozyme, Insulin-like growth factor, stem cell factor, epidermal growth factor, and others. Recombinant albumin was the dominant segment in terms of revenue in 2017 while recombinant epidermal growth factor (rEGF) segment is expected to be the fastest growing segment during the forecast period from 2018 to 2028.

Geographically, the market is segmented into five distinct regions including, North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World. North America, followed by Europe, is the leading contributor of the market. Within North America, the U.S. contributed to almost 93% of the total share, and the rest of the share was occupied by Canada in 2017. Within Europe, Germany dominated the market in 2017. However, the market for the Asia-Pacific region is expected to witness the high growth rate, during the forecast period from 2018 to 2028, as compared to other regions.

The recombinant cell culture supplements market has a promising potential for the growth in the coming years with the increased usage of cell cultures and biotechnology in the modern day science. The report provides an in-depth SWOT analysis of different key players of the market, supported by extensive financial summary of each company. The key players of the market are Thermo Fisher Scientific, Hi-Media Laboratories, BBI Solutions, PeproTech, Inc., InVitria, Sino Biologicals, STEMCELL Technologies, Irvine Scientific, Merck KGaA, Corning Incoporated, Gemini Bio-Products, Novozyme A/S, and Repligen Corporation, among others.

Table of Contents

Executive Summary

1 Market Overview

  • 1.1 Fundamentals of Cell Culture
  • 1.2 Role of Media and Supplements
  • 1.3 Serum-free Media vs. Serum containing Media
  • 1.4 Technological Advancements of Defined Media and Importance of Recombinant Cell Culture Supplements
  • 1.5 Recombinant Cell Culture Supplements Market Scenario
  • 1.6 Assumptions and Limitations for Market Size Calculations

2 Market Dynamics

  • 2.1 Market Drivers
    • 2.1.1 Benefits of Using Recombinant Cell Culture Supplements
    • 2.1.2 Increase in Funding and Investment in R&D of Life Science Sector
    • 2.1.3 Rising Demand for Advanced Cell Culture Products
  • 2.2 Market Restraints
    • 2.2.1 High Cost of Cell Biology Research
    • 2.2.2 Technical Considerations Associated with Cell Culture
    • 2.2.3 Lack of Infrastructure and Skilled Professionals for Cell-based Research
  • 2.3 Market Opportunities
    • 2.3.1 Rising Demand for Monoclonal Antibodies and Stem Cell Research
    • 2.3.2 Increasing Preference for Serum-Free Media

3 Industry Insights

  • 3.1 Regulatory Scenario
  • 3.2 Patent Landscape

4 Competitive Landscape

  • 4.1 Key Developmental Strategies
    • 4.1.1 Product Launch
    • 4.1.2 Agreement, Collaboration, and Partnership
    • 4.1.3 Acquisition
    • 4.1.4 Business Expansion
    • 4.1.5 Others
  • 4.2 Market Share Analysis

5 Global Recombinant Cell Culture Supplements Market (by Products)

  • 5.1 Overview
  • 5.2 Supplements
    • 5.2.1 Recombinant Albumin (rAlbumin)
    • 5.2.2 Recombinant Insulin (rInsulin)
    • 5.2.3 Recombinant Epidermal Growth Factor (rEGF)
    • 5.2.4 Recombinant Transferrin (rTransferrin)
    • 5.2.5 Recombinant Trypsin (rTrypsin)
    • 5.2.6 Recombinant Insulin-like Growth Factor (rIGF)
    • 5.2.7 Recombinant Stem Cell Factor (SCF) Protein (rSCF)
    • 5.2.8 Recombinant Aprotinin (rAprotinin)
    • 5.2.9 Recombinant Lysozyme (rLysozyme)
    • 5.2.10 Others

6 Global Recombinant Cell Culture Supplements Market (by Application)

  • 6.1 Overview
  • 6.2 Stem Cell and Regenerative Medicine
  • 6.3 BioProduction
  • 6.4 Academic and Research Application

7 Global Recombinant Cell Culture Supplements Market (by Region)

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 The U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 France
    • 7.3.3 The U.K.
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 The Netherlands
    • 7.3.7 Rest-of-Europe
  • 7.4 Asia-Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 S. Korea
    • 7.4.4 India
    • 7.4.5 Australia
    • 7.4.6 Rest-of-Asia-Pacific
  • 7.5 Latin-America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Rest-of-Latin America
  • 7.6 Rest of the World (RoW)
    • 7.6.1 Russia
    • 7.6.2 Israel
    • 7.6.3 Kingdom of Saudi Arabia (K.S.A.)
    • 7.6.4 Others

8 Company Profiles

  • 8.1 BBI Solutions
    • 8.1.1 Company Overview
    • 8.1.2 Role of BBI Solutions in the Recombinant Cell Culture Supplements Market
    • 8.1.3 SWOT Analysis
  • 8.2 Corning Incorporated
    • 8.2.1 Company Overview
    • 8.2.2 Role of Corning Incorporated in Recombinant Cell Culture Supplements Market
    • 8.2.3 Financials
    • 8.2.4 Key Insights on Financial Health of the Company
    • 8.2.5 Global Presence
    • 8.2.6 SWOT Analysis
  • 8.3 Evercyte GmbH
    • 8.3.1 Company Overview
    • 8.3.2 Role of Evercyte GmbH in Recombinant Cell Culture Supplements Market
    • 8.3.3 SWOT Analysis
  • 8.4 Gemini Bio-Products
    • 8.4.1 Company Overview
    • 8.4.2 Role of Gemini Bio-Products in Recombinant Cell Culture Supplements Market
    • 8.4.3 SWOT Analysis
  • 8.5 HiMedia Laboratories
    • 8.5.1 Company Overview
    • 8.5.2 Role of HiMedia Laboratories in Recombinant Cell Culture Supplements Market
    • 8.5.3 SWOT Analysis
  • 8.6 InVitria
    • 8.6.1 Company Overview
    • 8.6.2 Role of InVitria in the Recombinant Cell Culture Supplements Market
    • 8.6.3 SWOT Analysis
  • 8.7 Irvine Scientific
    • 8.7.1 Company Overview
    • 8.7.2 Role of Irvine Scientific in Global Recombinant Cell Culture Supplements Market
    • 8.7.3 SWOT Analysis
  • 8.8 Kingfisher Biotech, Inc.
    • 8.8.1 Company Overview
    • 8.8.2 Role of Kingfisher Biotech, Inc. in Recombinant Cell Culture Supplements Market
    • 8.8.3 SWOT Analysis
  • 8.9 Lonza Group
    • 8.9.1 Company Overview
    • 8.9.2 Role of Lonza in Recombinant Cell Culture Supplements Market
    • 8.9.3 Financials
    • 8.9.4 Key Insights on Financial Health of the Company
    • 8.9.5 Global Presence
    • 8.9.6 SWOT Analysis
  • 8.10 Merck KGaA
    • 8.10.1 Company Overview
    • 8.10.2 Role of Merck KGaA in Recombinant Cell Culture Supplements Market
    • 8.10.3 Financials
    • 8.10.4 Key Insights on the Financial Health of Company
    • 8.10.5 Global Presence
    • 8.10.6 SWOT Analysis
  • 8.11 Novozymes
    • 8.11.1 Company Overview
    • 8.11.2 Role of Novozymes in Recombinant Cell Culture Supplements Market
    • 8.11.3 Financials
    • 8.11.4 Key Insights on Financial Health of the Company
    • 8.11.5 Global Presence
    • 8.11.6 SWOT Analysis
  • 8.12 PeproTech, Inc.
    • 8.12.1 Company Overview
    • 8.12.2 Role of PeproTech, Inc. in the Recombinant Cell Culture Supplements Market
    • 8.12.3 SWOT Analysis
  • 8.13 Repligen Corporation
    • 8.13.1 Company Overview
    • 8.13.2 Role of Repligen Corporation in the Recombinant Cell Culture Supplements Market
    • 8.13.3 Financials
    • 8.13.4 Key Insights on Financial Health of the Company
    • 8.13.5 Global Presence
    • 8.13.6 SWOT Analysis
  • 8.14 Shenandoah Biotechnology
    • 8.14.1 Company Overview
    • 8.14.2 Role of Shenandoah Biotechnology in the Recombinant Cell Culture Supplements Market
    • 8.14.3 SWOT Analysis
  • 8.15 Sino Biological Inc.
    • 8.15.1 Company Overview
    • 8.15.2 Role of Sino Biological Inc. in the Recombinant Cell Culture Supplements Market
    • 8.15.3 SWOT Analysis
  • 8.16 STEMCELL Technologies Inc.
    • 8.16.1 Company Overview
    • 8.16.2 Role of STEMCELL Technologies Inc. in the Recombinant Cell Culture Supplements Market
    • 8.16.3 SWOT Analysis
  • 8.17 Thermo Fisher Scientific
    • 8.17.1 Company Overview
    • 8.17.2 Role of Thermo Fisher Scientific in the Recombinant Cell Culture Supplements Market
    • 8.17.3 Financials
    • 8.17.4 Key Insights on the Financial Health of the Company
    • 8.17.5 Global Presence
    • 8.17.6 SWOT Analysis
  • 8.18 Albumedix: Snapshot
    • 8.18.1 Company Overview
    • 8.18.2 Product Portfolio

9 Research Scope and Methodology

  • 9.1 Scope of the Report
  • 9.2 Global Recombinant Cell Culture Supplements Market Segmentation
  • 9.3 Research Methodology
    • 9.3.1 Primary Research
    • 9.3.2 Secondary Research
    • 9.3.3 Key Data Points from Primary and Secondary Sources
    • 9.3.4 Data Triangulation
    • 9.3.5 Top-Down Approach
    • 9.3.6 Bottom- Up Approach
  • 9.4 Assumptions and Limitations

List of Tables

  • Table 1.1 Recombinant Cell-Culture Supplements Product Offerings of Some Key Companies
  • Table 2.1 Impact Analysis of Market Dynamics
  • Table 3.1 Global Regulatory Scenario
  • Table 3.2 Patents Granted between January 2015 and March 2018
  • Table 5.1 Recombinant Albumin Products
  • Table 5.2 Global Recombinant Albumin Market (by Application), 2017-2028, $Million
  • Table 5.3 Global Recombinant Insulin Market (by Application), 2017-2028, $Million
  • Table 5.4 Recombinant EGF Products
  • Table 5.5 Global Recombinant EGF Market (by Application), 2017-2028, $Million
  • Table 5.6 Recombinant Transferrin Products
  • Table 5.7 Global Recombinant Transferrin Market (by Application), 2017-2028, $Million
  • Table 5.8 Recombinant Trypsin Products
  • Table 5.9 Global Recombinant Trypsin Market (by Application), 2017-2028, $Million
  • Table 5.10 Recombinant IGF-I Products
  • Table 5.11 Global Recombinant IGF-I Market (by Application), 2017-2028, $Million
  • Table 5.12 Global Recombinant SCF Supplement Products
  • Table 5.13 Global Recombinant SCF Market (by Application), 2017-2028, $Million
  • Table 5.14 Recombinant Aprotinin Products
  • Table 5.15 Global Recombinant Aprotinin Market (by Application), 2017-2028, $Million
  • Table 5.16 Recombinant Lysozyme Products
  • Table 5.17 Global Recombinant Lysozyme Market (by Application), 2017-2028, $Million
  • Table 5.18 Global Recombinant Others Supplement Products
  • Table 5.19 Global Recombinant Others Supplements Market (by Application), 2017-2028, $Million
  • Table 6.1 Companies along with Biomanufacturing Facility
  • Table 7.1 Global Recombinant Cell Culture Supplements Market (by Region), 2017-2028, $Million
  • Table 7.2 North America Recombinant Cell Culture Supplements Market (by Product), 2017-2028, $Million
  • Table 7.3 Europe Recombinant Cell Culture Supplements Market (by Product), 2017-2028, $Million
  • Table 7.4 Asia-Pacific Recombinant Cell Culture Supplements Market (by Product), 2017-2028, $Million
  • Table 7.5 Latin America Recombinant Cell Culture Supplements Market (by Product), 2017-2028, $Million
  • Table 7.6 RoW Recombinant Cell Culture Supplements Market (by Product), 2017-2028, $Million

List of Figures

  • Figure 1 Global Recombinant Cell Culture Supplements Market, 2017-2028
  • Figure 2 Global Recombinant Cell Culture Supplements Market (by Product), 2017 and 2028
  • Figure 3 Global Recombinant Cell Culture Supplements Market (by Application), 2017 and 2028
  • Figure 4 Global Recombinant Cell Culture Supplements Market (by Region), 2017 and 2028
  • Figure 1.1 Important Terminology of Cell Culture Procedure
  • Figure 1.2 Market for Global Recombinant Cell Culture Supplements
  • Figure 1.3 Global Recombinant Cell Culture Supplements Market, 2017-2028
  • Figure 1.4 Recombinant Cell Culture Supplements Market Segmentation
  • Figure 4.1 Share of Key Developmental Strategies, January 2015-July 2018
  • Figure 4.2 Share of Product Launch (by Company), January 2015-July 2018
  • Figure 4.3 Share of Agreement, Collaboration, and Partnership (by Company), January 2015-July 2018
  • Figure 4.4 Share of Acquisition (by Company), January 2015-July 2018
  • Figure 4.5 Share of Business Expansion (by Company), January 2015-July 2018
  • Figure 4.6 Share of Other Developments (by Company), January 2015-July 2018
  • Figure 4.7 Global Recombinant Cell Culture Supplements Market Share of Key Players, 2017 and 2018
  • Figure 4.8 Growth Share Matrix, (by Company)2018
  • Figure 5.1 Different Types of Cell Culture Products
  • Figure 5.2 Global Recombinant Cell Culture Supplements Market (by Product), 2017-2028
  • Figure 5.3 Global Recombinant Albumin Market, 2017-2028
  • Figure 5.4 Global Recombinant Insulin Market, 2017-2028
  • Figure 5.5 Global Recombinant EGF Market, 2017-2028
  • Figure 5.6 Global Recombinant Transferrin Market, 2017-2028
  • Figure 5.7 Features of Recombinant Trypsin
  • Figure 5.8 Global Recombinant Trypsin Market, 2017-2028
  • Figure 5.9 Global Recombinant IGF-I Market, 2017-2028
  • Figure 5.10 Global Recombinant SCF Market, 2017-2028
  • Figure 5.11 Global Recombinant Aprotinin Market, 2017-2028
  • Figure 5.12 Global Recombinant Lysozyme Market, 2017-2028
  • Figure 5.13 Global Recombinant Other Supplements Market, 2017-2028
  • Figure 6.1 Global Recombinant Cell Culture Supplements (by Application)
  • Figure 6.2 Global Recombinant Cell Culture Supplements (by Application), 2017-2028
  • Figure 6.3 Regenerative Medicine: Present and Future
  • Figure 6.4 Types of Stem Cells
  • Figure 6.5 Global Recombinant Cell Culture Supplements Market (by Stem Cells and Regenerative Medicine), 2017-2028
  • Figure 6.6 Global Recombinant Cell Culture Supplements Market (by Bioproduction), 2017-2028
  • Figure 6.7 Global Recombinant Cell Culture Supplements Market (by Academic and Research), 2017-2028
  • Figure 7.1 Global Recombinant Cell Culture Supplements Market, 2017-2028
  • Figure 7.2 North America Recombinant Cell Culture Supplements Market, 2017-2028
  • Figure 7.3 North America Recombinant Cell Culture Supplements Market (by Country), 2017-2028
  • Figure 7.4 U.S. Recombinant Cell Culture Supplements Market, 2017-2028
  • Figure 7.5 Canada Recombinant Cell Culture Supplements Market, 2017-2028
  • Figure 7.6 Europe Recombinant Cell Culture Supplements Market, 2017-2028
  • Figure 7.7 Europe Recombinant Cell Culture Supplements Market (by Country), 2017-2028
  • Figure 7.8 Germany Recombinant Cell Culture Supplements Market, 2017-2028
  • Figure 7.9 France Recombinant Cell Culture Supplements Market, 2017-2028
  • Figure 7.10 The U.K. Recombinant Cell Culture Supplements Market, 2017-2028
  • Figure 7.11 Italy Recombinant Cell Culture Supplements Market, 2017-2028
  • Figure 7.12 Spain Recombinant Cell Culture Supplements Market, 2017-2028
  • Figure 7.13 The Netherlands Recombinant Cell Culture Supplements Market, 2017-2028
  • Figure 7.14 Rest-of-Europe Recombinant Cell Culture Supplements Market, 2017-2028
  • Figure 7.15 Asia-Pacific Recombinant Cell Culture Supplements Market, 2017-2028
  • Figure 7.16 Asia-Pacific Recombinant Cell Culture Supplements Market (by Country), 2017-2028
  • Figure 7.17 China Recombinant Cell Culture Supplements Market, 2017-2028
  • Figure 7.18 Japan Recombinant Cell Culture Supplements Market, 2017-2028
  • Figure 7.19 S.Korea Recombinant Cell Culture Supplements Market, 2017-2028
  • Figure 7.20 India Recombinant Cell Culture Supplements Market, 2017-2028
  • Figure 7.21 Australia Recombinant Cell Culture Supplements Market, 2017-2028
  • Figure 7.22 Rest-of-Asia-Pacific Recombinant Cell Culture Supplements Market, 2017-2028
  • Figure 7.23 Latin America Recombinant Cell Culture Supplements Market, 2017-2028
  • Figure 7.24 Latin America Recombinant Cell Culture Supplements Market (by Country), 2017-2028
  • Figure 7.25 Brazil Recombinant Cell Culture Supplements Market (by Country), 2017-2028
  • Figure 7.26 Mexico Recombinant Cell Culture Supplements Market (by Country), 2017-2028
  • Figure 7.27 Rest-of-Latin-America Recombinant Cell Culture Supplements Market (by Country), 2017-2028
  • Figure 7.28 RoW Recombinant Cell Culture Supplements Market 2017-2028
  • Figure 7.29 RoW Recombinant Cell Culture Supplements Market (by Country), 2017-2028
  • Figure 7.30 Russia Recombinant Cell Culture Supplements Market, 2017-2028
  • Figure 7.31 Israel Recombinant Cell Culture Supplements Market, 2017-2028
  • Figure 7.32 K.S.A. Recombinant Cell Culture Supplements Market, 2017-2028
  • Figure 7.33 Others Recombinant Cell Culture Supplements Market, 2017-2028
  • Figure 8.1 Contribution of Public and Private Company Profiles
  • Figure 8.2 BBI Solutions: Product Offerings for Global Recombinant Cell Culture Supplements Market
  • Figure 8.3 BBI Solutions: SWOT Analysis
  • Figure 8.4 Corning Incorporated: Product Offerings for Global Recombinant Cell Culture Supplements Market
  • Figure 8.5 Corning Incorporated: Overall Financials, 2015-2017
  • Figure 8.6 Corning Incorporated: Revenue (by Business Segment), 2015-2017
  • Figure 8.7 Corning Incorporated: Revenue (by Region), 2015-2017
  • Figure 8.8 Corning Incorporated: R&D Expense, 2015-2017
  • Figure 8.9 Corning Incorporated: Revenue Forecast, 2015-2020
  • Figure 8.10 Corning Incorporated: Global Presence
  • Figure 8.11 Corning Incorporated: SWOT Analysis
  • Figure 8.12 Evercyte GmbH: Product Offerings for Global Recombinant Cell Culture Supplements Market
  • Figure 8.13 Evercyte GmbH: SWOT Analysis
  • Figure 8.14 Gemini Bio-Products Offerings for Global Recombinant Cell Culture Supplements Market
  • Figure 8.15 Gemini Bio-Products: SWOT Analysis
  • Figure 8.16 HiMedia Laboratories: Product Offerings for Global Recombinant Cell Culture Supplements Market
  • Figure 8.17 Himedia Laboratories: SWOT Analysis
  • Figure 8.18 InVitria: Product Offerings for Global Recombinant Cell Culture Supplements Market
  • Figure 8.19 InVitria: SWOT Analysis
  • Figure 8.20 Irvine Scientific: Product Offerings for Global Recombinant Cell Culture Supplements Market
  • Figure 8.21 Irvine Scientific: SWOT Analysis
  • Figure 8.22 Kingfisher Biotech, Inc.: Product Offerings for Global Recombinant Cell Culture Supplements Market
  • Figure 8.23 Kingfisher Biotech, Inc.: SWOT Analysis
  • Figure 8.24 Lonza Group: Product Offerings for Global Recombinant Cell Culture Supplements Market
  • Figure 8.25 Lonza Group: Overall Financials, 2015-2017
  • Figure 8.26 Lonza Group: Revenue (by Business Segment), 2015-2017
  • Figure 8.27 Lonza Group: Revenue (by Region), 2015-2017
  • Figure 8.28 Lonza Group: R&D Expense, 2015-2017
  • Figure 8.29 Lonza Group: Revenue Forecast, 2015-2020
  • Figure 8.30 Lonza Group: Global Presence
  • Figure 8.31 Lonza Group: SWOT Analysis
  • Figure 8.32 Merck KGaA: Product Offerings for Global Recombinant Cell Culture Supplements Market
  • Figure 8.33 Merck KGaA: Overall Financials, 2015-2017
  • Figure 8.34 Merck KGaA: Revenue (by Business Segment), 2015-2017
  • Figure 8.35 Merck KGaA: Revenue (by Region), 2015-2017
  • Figure 8.36 Merck KGaA: R&D Expense, 2015-2017
  • Figure 8.37 Merck KGaA: Revenue Forecast, 2015-2020
  • Figure 8.38 Merck KGaA: Global Presence
  • Figure 8.39 Merck KGaA: SWOT Analysis
  • Figure 8.40 Novozymes: Product Offerings for Global Recombinant Cell Culture Supplements Market
  • Figure 8.41 Novozymes: Overall Financials, 2015-2017
  • Figure 8.42 Novozymes: Revenue (by Business Segment), 2015-2017
  • Figure 8.43 Novozymes: Revenue (by Region), 2015-2017
  • Figure 8.44 Novozymes: R&D Expense, 2015-2017
  • Figure 8.45 Novozymes: Revenue Forecast, 2015-2020
  • Figure 8.46 Novozymes: Global Presence
  • Figure 8.47 Novozymes: SWOT Analysis
  • Figure 8.48 PeproTech, Inc.: Product Offerings for Global Recombinant Cell Culture Supplements Market
  • Figure 8.49 PeproTech, Inc.: Recombinant Proteins for Cell Culture under Growth Factor and Cytokines Segment
  • Figure 8.50 PeproTech, Inch: SWOT Analysis
  • Figure 8.51 Repligen: Product Offerings for Global Recombinant Cell Culture Supplements Market
  • Figure 8.52 Repligen Corporation: Overall Financials, 2015-2017
  • Figure 8.53 Repligen Corporation: Revenue (by Business Segment), 2015-2017
  • Figure 8.54 Repligen Corporation: Revenue (by Geography), 2015-2017
  • Figure 8.55 Repligen Corporation: R&D Expense, 2015-2017
  • Figure 8.56 Repligen Corporation: Revenue Forecast, 2015-2020
  • Figure 8.57 Repligen Corporation: Global Presence
  • Figure 8.58 Repligen Corporation: SWOT Analysis
  • Figure 8.59 Shenandoah Biotechnology Inc Offerings for Global Recombinant Cell Culture Supplements Market
  • Figure 8.60 Shenandoah Biotechnology Inc: SWOT Analysis
  • Figure 8.61 Sino Biological Inc.: Product Offerings for Global Recombinant Cell Culture Supplements Market
  • Figure 8.62 Sino Biological Inc.: SWOT Analysis
  • Figure 8.63 STEMCELL Technologies Inc.: Product Offerings for Global Recombinant Cell Culture Supplements Market
  • Figure 8.64 STEMCELL Technologies Inc.: SWOT Analysis
  • Figure 8.65 Thermo Fisher Scientific: Product Offerings for Global Recombinant Cell Culture Supplements Market
  • Figure 8.66 Thermo Fisher Scientific: Overall Financials, 2015-2017
  • Figure 8.67 Thermo Fisher Scientific: Revenue (by Business Segment), 2015-2017
  • Figure 8.68 Thermo Fisher Scientific: Revenue (by Region), 2015-2017
  • Figure 8.69 Thermo Fisher Scientific: R&D Expense, 2015-2017
  • Figure 8.70 Thermo Fisher Scientific: Revenue Forecast, 2015-2020
  • Figure 8.71 Thermo Fisher Scientific: Global Presence
  • Figure 8.72 Thermo Fisher Scientific: SWOT Analysis
  • Figure 8.73 Albumedix: Product Offerings for Global Recombinant Cell Culture Supplements Market
  • Figure 9.1 Global Recombinant Cell Culture Supplements Market Segmentation
  • Figure 9.2 Research Methodology
  • Figure 9.3 Key Data Points from Primary and Secondary Sources
  • Figure 9.4 Data Triangulation
  • Figure 9.5 Top-down Approach: Global Recombinant Cell Culture Supplements Market
  • Figure 9.6 Bottom-up Approach: Global Recombinant Cell Culture Supplements Market
  • Figure 9.7 Assumptions and Limitations
Back to Top